Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc
Description
Thromboinflammation is the major cause of morbidity and mortality in COVID-19 patients, and post-mortem examination demonstrates the presence of platelet-rich thrombi and microangiopathy in visceral organs. Moreover, persistent microclots were
